Mark G. Saulnier,David B. Frennesson,Makonen Belema
申请号：
US14904852
公开号：
US20160166545A1
申请日:
2014.07.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
